NF1 and lung cancer: The oncosuppressor activity of NF1 has been later confirmed by the findings of somatic NF1 mutations in many human cancers, including breast cancer [37], ovarian cancer [38], lung cancer [39], glioblastoma [40] and acute myeloid leukemia [41].